SequelSEC

Autonomix Medical, Inc. AMIX

Surgical & Medical Instruments & Apparatus · CIK 0001617867 · Fiscal year ends 0331

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2026-06-30
Operating income
-$16.38M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Autonomix Medical, Inc. (AMIX) reported revenue of $0 and net income of -$16.10M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Autonomix Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Autonomix Medical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$16.38M
Net income-$16.10M
Research & development$7.07M
Weighted-average diluted sharesUnavailable
Pretax income-$16.11M
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$9.32M
Selling & marketingUnavailable

Balance

Autonomix Medical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$3.46M
Total assets$3.98M
Current assets$3.96M
Total liabilities$818.00K
Current liabilities$818.00K
Total equity incl. NCI$3.16M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$371.00K

Cash flow

Autonomix Medical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$13.22M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$8.10M
Net change in cash-$5.13M
Stock-based compensation$143.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$12.00K

Derived

Autonomix Medical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio4.85x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AMIX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-K · Filed 2026-05-27View SEC filing
10-Q · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-K · Filed 2025-05-29View SEC filing

Companies in the same industry

ADGM AEMD ALUR ANGO ANIK AORT APYX ARAY ATEC ATRC AURX BAX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.